Department of Psychology, College of Mount Saint Vincent, Bronx, New York, USA.
Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Ann Clin Transl Neurol. 2024 Feb;11(2):291-301. doi: 10.1002/acn3.51951. Epub 2023 Nov 28.
To examine associations between neurologic late effects and attainment of independence in adult survivors of childhood cancer treated with central nervous system (CNS)-directed therapies.
A total of 7881 survivors treated with cranial radiation therapy (n = 4051; CRT) and/or intrathecal methotrexate (n = 4193; IT MTX) ([CNS-treated]; median age [range] = 25.5 years [18-48]; time since diagnosis = 17.7 years [6.8-30.2]) and 8039 without CNS-directed therapy reported neurologic conditions including stroke, seizure, neurosensory deficits, focal neurologic dysfunction, and migraines/severe headaches. Functional independence was assessed using latent class analysis with multiple indicators (independent living, assistance with routine and personal care needs, ability to work/attend school, attainment of driver's license, marital/partner status). Multivariable regression models, adjusted for age, sex, race/ethnicity, and chronic health conditions, estimated odds ratios (OR) or relative risks (RR) for associations between neurologic morbidity, functional independence, and emotional distress.
Among CNS-treated survivors, three classes of independence were identified: (1) moderately independent, never married, and non-independent living (78.7%); (2) moderately independent, unable to drive (15.6%); and (3) non-independent (5.7%). In contrast to 50% of non-CNS-treated survivors and 60% of siblings, a fourth fully independent class of CNS-treated survivors was not identified. History of stroke (OR = 2.50, 95% CI: 1.70-3.68), seizure (OR = 9.70, 95% CI: 7.37-12.8), neurosensory deficits (OR = 2.67, 95% CI: 2.16-3.31), and focal neurologic dysfunction (OR = 3.05, 95% CI: 2.40-3.88) were associated with non-independence among CNS-treated survivors. Non-independence was associated with emotional distress symptoms.
CNS-treated survivors do not attain full independence comparable to non-CNS-treated survivors or siblings. Interventions to promote independence may be beneficial for survivors with treatment-related neurological sequalae.
研究接受中枢神经系统(CNS)定向治疗的儿童癌症幸存者的神经晚期效应与成年后独立的相关性。
共纳入 7881 例接受颅放射治疗(n=4051;CRT)和/或鞘内甲氨蝶呤(n=4193;IT MTX)治疗的幸存者([CNS 治疗组];中位年龄[范围]为 25.5 岁[18-48];诊断后时间为 17.7 年[6.8-30.2])和 8039 例未接受 CNS 定向治疗的幸存者,报告有卒中、癫痫、神经感觉缺陷、局灶性神经功能障碍和偏头痛/严重头痛等神经疾病。采用具有多个指标的潜在类别分析评估独立生活能力(独立生活、日常和个人护理需求帮助、工作/上学能力、获得驾驶执照、婚姻/伴侣状况)。多变量回归模型,根据年龄、性别、种族/民族和慢性健康状况进行调整,评估神经发病率、功能独立性和情绪困扰之间关联的比值比(OR)或相对风险(RR)。
在 CNS 治疗组幸存者中,发现了三种独立类别的生存状态:(1)中度独立,未婚且无独立生活能力(78.7%);(2)中度独立,无法驾驶(15.6%);(3)无独立生活能力(5.7%)。与 50%的非 CNS 治疗组幸存者和 60%的兄弟姐妹相比,未识别出第四种完全独立的 CNS 治疗组幸存者类别。卒中史(OR=2.50,95%CI:1.70-3.68)、癫痫(OR=9.70,95%CI:7.37-12.8)、神经感觉缺陷(OR=2.67,95%CI:2.16-3.31)和局灶性神经功能障碍(OR=3.05,95%CI:2.40-3.88)与 CNS 治疗组幸存者的非独立性相关。非独立性与情绪困扰症状有关。
CNS 治疗组幸存者无法达到与非 CNS 治疗组幸存者或兄弟姐妹相当的完全独立状态。促进独立的干预措施可能对有治疗相关神经后遗症的幸存者有益。